Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irja Lutsar

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Current Opinion in Infectious Diseases|February 25, 2010
Understanding pharmacokinetics/pharmacodynamics in managing neonatal sepsisIrja Lutsar, Tuuli Metsvaht
Expert Review of Anti-Infective Therapy|September 6, 2014
Treatment option for sepsis in children in the era of antibiotic resistanceIrja Lutsar, Kaidi Telling, Tuuli Metsvaht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patientsIrja Lutsar, Sarah Roffey, Peter Troke
Infectious Disorders Drug Targets|May 17, 2013
Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and childrenJoseph F Standing, Maria Tsolia, Irja Lutsar
Vaccine|August 17, 2015
Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological studyPiia Jõgi, Marje Oona, Karolin Toompere, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studiesMats O Karlsson, Irja Lutsar, Peter A Milligan
Journal of Pharmacokinetics and Pharmacodynamics|February 24, 2024
Subgroup identification-based model selection to improve the predictive performance of individualized dosingHiie Soeorg, Riste Kalamees, Irja Lutsar, et al.
Springerplus|May 14, 2013
Antibiotic prescription preferences in paediatric outpatient setting in Estonia and SwedenJana Lass, Viveca Odlind, Alar Irs, et al.
Scandinavian Journal of Infectious Diseases|May 20, 2006
Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccineSirli Meriste, Irja Lutsar, Eda Tamm, et al.
Nutrition Research (New York, N.Y.)|April 30, 2015
Gut colonization by aerobic microorganisms is associated with route and type of nutrition in premature neonatesÜlle Parm, Tuuli Metsvaht, Mari-Liis Ilmoja, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Current Opinion in Infectious Diseases|February 25, 2010
Understanding pharmacokinetics/pharmacodynamics in managing neonatal sepsisIrja Lutsar, Tuuli Metsvaht
Expert Review of Anti-Infective Therapy|September 6, 2014
Treatment option for sepsis in children in the era of antibiotic resistanceIrja Lutsar, Kaidi Telling, Tuuli Metsvaht
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patientsIrja Lutsar, Sarah Roffey, Peter Troke
Infectious Disorders Drug Targets|May 17, 2013
Pharmacokinetics and pharmacodynamics of oseltamivir in neonates, infants and childrenJoseph F Standing, Maria Tsolia, Irja Lutsar
Vaccine|August 17, 2015
Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological studyPiia Jõgi, Marje Oona, Karolin Toompere, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studiesMats O Karlsson, Irja Lutsar, Peter A Milligan
Journal of Pharmacokinetics and Pharmacodynamics|February 24, 2024
Subgroup identification-based model selection to improve the predictive performance of individualized dosingHiie Soeorg, Riste Kalamees, Irja Lutsar, et al.
Springerplus|May 14, 2013
Antibiotic prescription preferences in paediatric outpatient setting in Estonia and SwedenJana Lass, Viveca Odlind, Alar Irs, et al.
Scandinavian Journal of Infectious Diseases|May 20, 2006
Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccineSirli Meriste, Irja Lutsar, Eda Tamm, et al.
Nutrition Research (New York, N.Y.)|April 30, 2015
Gut colonization by aerobic microorganisms is associated with route and type of nutrition in premature neonatesÜlle Parm, Tuuli Metsvaht, Mari-Liis Ilmoja, et al.
Pageof 14